Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.
NCT ID: NCT06259487
Last Updated: 2024-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
250 participants
INTERVENTIONAL
2023-09-15
2024-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
• Does coordinated care through vaccinations improve the prognosis of patients with chronic heart failure?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaccination Against Influenza Pre-discharge in Heart Failure
NCT06725927
Flu Vaccination in Congestive Heart Failure
NCT00664339
Respiratory Virus Infections in Acute Heart Failure
NCT06967441
Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician
NCT06360315
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
NCT02268500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coordinated Vaccination against RSV and Influenza
Patients receiving vaccinations against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e. during cardiology visits).
Coordinated Vaccination
Coordinated Vaccination against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e., during cardiology visits)
Standard of care
Patients following standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points).
Following recommendations
Guidance on following the standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coordinated Vaccination
Coordinated Vaccination against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e., during cardiology visits)
Following recommendations
Guidance on following the standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to provide informed consent for participation in the study
* Diagnosis of heart failure
* No previous vaccination against RSV or influenza
Exclusion Criteria
* Hypersensitivity to any component of the vaccine
* Receipt of vaccination against RSV or influenza in the current infectious
* Active infection
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wroclaw Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Biegus, MD, PhD
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wroclaw Medical University
Wroclaw, Dolnyslask, Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Biegus J, Szenborn L, Zymlinski R, Zakliczynski M, Reczuch K, Guzik M, Urban S, Rosiek-Biegus M, Jankowiak B, Iwanek G, Fudim M, Ponikowski P. The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure. Vaccine. 2024 Apr 30;42(12):2937-2940. doi: 10.1016/j.vaccine.2024.03.060. Epub 2024 Mar 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
325/2023N
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.